William DuVal

Full contact info

I love helping my clients launch and grow their businesses.

About William

William represents both companies and investors in a range of industries. His practice focuses on venture capital financings, mergers and acquisitions, and corporate governance.

Prior to practicing law, William worked as a business manager at Capital One. He focused on rewards currency analytics, digital marketing and new product development.

William received his JD/MBA from the University of Virginia where he was president of the JD/MBA Society. He received his BS from the University of Virginia McIntire School of Commerce, with concentrations in finance and marketing.

Representative company-side and underwriter-side public offerings:

  • Aclaris Therapeutics – $92.9 million follow-on offering
  • Epizyme – $75 million follow-on offering
  • Argenx SE – $86.5 million follow-on offering
  • Autolus Therapeutics – $150 million IPO
  • Helius Medical Technologies – $16 million follow-on offering
  • Biohaven Pharmaceutical Holding – $193.6 million IPO


University of Virginia School of Law
JD, 2016

University of Virginia Darden School of Business
MBA, 2016

University of Virginia McIntire School of Commerce
BS, 2008